TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H209. A total of 22 filers reported holding TRACON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $333,000 | +41.1% | 85,993 | +136.4% | 0.03% | +25.9% |
| Q2 2021 | $236,000 | +11.8% | 36,370 | +41.8% | 0.03% | -22.9% |
| Q1 2021 | $211,000 | -61.1% | 25,650 | -44.7% | 0.04% | -60.7% |
| Q4 2020 | $543,000 | +28.7% | 46,375 | -43.2% | 0.09% | +27.1% |
| Q3 2020 | $422,000 | – | 81,675 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 4,764,508 | $848,082 | 0.28% |
| Ikarian Capital, LLC | 2,765,530 | $492,265 | 0.06% |
| JOHNSON & JOHNSON | 84,003 | $14,953 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 258,844 | $46,074 | 0.00% |
| BlackRock Inc. | 267,821 | $47,673 | 0.00% |
| Bank of New York Mellon Corp | 10,259 | $1,826 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 15,835 | $2,819 | 0.00% |
| Truvestments Capital LLC | 318 | $57 | 0.00% |
| Tower Research Capital LLC (TRC) | 10,407 | $1,852 | 0.00% |
| Cutler Group LLC / CA | 1,200 | $0 | 0.00% |